Three Months Ended March 31,

(in thousands, except per share amounts)

2023

2022

Net income (loss)

$

4,694

$

(12,524)

Less: Net (income) loss attributable to non-controlling interests

(1,749)

5,259

Net income (loss) attributable to Enfusion, Inc.

$

2,945

$

(7,265)

Numerator:

Net income (loss) attributable to Enfusion, Inc.

$

2,945

$

(7,265)

Adjustment to income (loss) attributable to common stockholders

226

(716)

Numerator for Basic Earnings per Share

$

3,171

$

(7,981)

Adjustment to Income for Dilutive Shares

1,523

-

Numerator for Diluted Earnings per Share

$

4,694

$

(7,981)

Denominator:

Weighted-average shares of Class A common stock outstanding

72,272

65,583

Vested shares of Class A common stock and RSUs

16,591

17,801

Weighted-average shares of Class A common stock outstanding--basic

88,863

83,384

Add: Dilutive Shares

43,483

-

Weighted-average shares of Class A common stock outstanding--diluted

132,346

83,384

Net income (loss) per share of Class A common stock--Basic

$

0.04

$

(0.10)

Net income (loss) per share of Class A common stock--Diluted

$

0.04

$

(0.10)